These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 19411388

  • 1. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
    Karlsson J, Pivodic A, Aguirre D, Schnitzer TJ.
    J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
    Schnitzer TJ, Kivitz A, Frayssinet H, Duquesroix B.
    Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
    [Abstract] [Full Text] [Related]

  • 3. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 4. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ, Kivitz AJ, Lipetz RS, Sanders N, Hee A.
    Arthritis Rheum; 2005 Dec 15; 53(6):827-37. PubMed ID: 16342089
    [Abstract] [Full Text] [Related]

  • 6. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.
    White WB, Schnitzer TJ, Fleming R, Duquesroix B, Beekman M.
    Am J Cardiol; 2009 Sep 15; 104(6):840-5. PubMed ID: 19733721
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study.
    Schnitzer TJ, Hochberg MC, Marrero CE, Duquesroix B, Frayssinet H, Beekman M.
    Semin Arthritis Rheum; 2011 Feb 15; 40(4):285-97. PubMed ID: 20828790
    [Abstract] [Full Text] [Related]

  • 8. Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study.
    Baerwald C, Verdecchia P, Duquesroix B, Frayssinet H, Ferreira T.
    Arthritis Rheum; 2010 Dec 15; 62(12):3635-44. PubMed ID: 20722026
    [Abstract] [Full Text] [Related]

  • 9. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C, Sindet-Pederson S, Seymour RA, Hawkesford JE, Coulthard P, Lamey PJ, Gerry Cowan C, Wickens M, Jeppsson L, Dean AD, Svensson O.
    Clin Ther; 2006 Sep 15; 28(9):1279-95. PubMed ID: 17062301
    [Abstract] [Full Text] [Related]

  • 10. Effects of naproxcinod on blood pressure in patients with osteoarthritis.
    White WB, Schnitzer TJ, Bakris GL, Frayssinet H, Duquesroix B, Weber M.
    Am J Cardiol; 2011 May 01; 107(9):1338-45. PubMed ID: 21371681
    [Abstract] [Full Text] [Related]

  • 11. A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.
    Lohmander LS, McKeith D, Svensson O, Malmenäs M, Bolin L, Kalla A, Genti G, Szechinski J, Ramos-Remus C, STAR Multinational Study Group.
    Ann Rheum Dis; 2005 Mar 01; 64(3):449-56. PubMed ID: 15345500
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F.
    Clin Ther; 2004 Nov 01; 26(11):1774-82. PubMed ID: 15639689
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ, Weaver AL, Polis AB, Petruschke RA, Geba GP, VACT-1 and VACT-2 (Protocols 106 and 150) Study Groups.
    J Rheumatol; 2005 Jun 01; 32(6):1093-105. PubMed ID: 15940774
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A, Fairfax M, Sheldon EA, Xiang Q, Jones BA, Gammaitoni AR, Gould EM.
    Clin Ther; 2008 Dec 01; 30(12):2366-77. PubMed ID: 19167595
    [Abstract] [Full Text] [Related]

  • 15. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain.
    Choi CB, Song JS, Kang YM, Suh CH, Lee J, Choe JY, Lee CK, Shim SC, Chung WT, Song GG, Kim HA, Ji JD, Nam EJ, Park SH, Hong YH, Sheen DH, Lim MK, Seo YI, Sung YK, Kim TH, Lee JT, Bae SC.
    Clin Ther; 2007 Jul 01; 29(7):1381-9. PubMed ID: 17825689
    [Abstract] [Full Text] [Related]

  • 16. Responsiveness of the OARSI-OMERACT osteoarthritis pain and function measures.
    Bond M, Davis A, Lohmander S, Hawker G.
    Osteoarthritis Cartilage; 2012 Jun 01; 20(6):541-7. PubMed ID: 22425883
    [Abstract] [Full Text] [Related]

  • 17. A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis.
    Sadreddini S, Noshad H, Molaeefard M, Moloudi R, Ardalan MR, Ghojazadeh M.
    Int J Rheum Dis; 2009 Apr 01; 12(1):44-51. PubMed ID: 20374316
    [Abstract] [Full Text] [Related]

  • 18. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.
    Peloso PM, Bellamy N, Bensen W, Thomson GT, Harsanyi Z, Babul N, Darke AC.
    J Rheumatol; 2000 Mar 01; 27(3):764-71. PubMed ID: 10743822
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee.
    Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K.
    J Pain Symptom Manage; 2004 Jul 01; 28(1):59-71. PubMed ID: 15223085
    [Abstract] [Full Text] [Related]

  • 20. Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
    Smugar SS, Schnitzer TJ, Weaver AL, Rubin BR, Polis AB, Tershakovec AM.
    Curr Med Res Opin; 2006 Jul 01; 22(7):1353-67. PubMed ID: 16834834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.